ITOXI Corp. (KOSDAQ:052770)
South Korea
· Delayed Price · Currency is KRW 808.00
+21.00 (2.67%)
At close: Mar 21, 2025, 3:30 PM KST
ITOXI Revenue
ITOXI had revenue of 4.41B KRW in the quarter ending September 30, 2024, with 58.64% growth. This brings the company's revenue in the last twelve months to 15.62B, down -45.02% year-over-year. In the year 2023, ITOXI had annual revenue of 21.65B, down -23.07%.
Revenue (ttm)
15.62B
Revenue Growth
-45.02%
P/S Ratio
2.20
Revenue / Employee
244.09M
Employees
64
Market Cap
38.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 21.65B | -6.49B | -23.07% |
| Dec 31, 2022 | 28.14B | 16.48B | 141.26% |
| Dec 31, 2021 | 11.66B | 2.94B | 33.70% |
| Dec 31, 2020 | 8.72B | 4.95B | 131.11% |
| Dec 31, 2019 | 3.77B | -10.68B | -73.89% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |